Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer
- 1 August 2006
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 91 (2) , 178-180
- https://doi.org/10.1111/j.1423-0410.2006.00810.x
Abstract
Leishmaniasis is a disease caused by protozoan parasites of the genus Leishmania, which are intracellular parasites of monocytes and macrophages. Transmission of the organism has been observed by transfusion of infected blood from asymptomatic donors to immunocompromised recipients, leading to clinically apparent disease. There is no licensed Leishmania screening test currently available. This study investigated the potential for a novel DNA-intercalating photosensitizer, thiopyrylium (TP), to inactivate Leishmania donovani infantum in red cell (RBC) suspensions. A 5.7 TCID50 reduction of Leishmania was observed in samples treated with 12.5 micromole l(-1) TP and 1.1 J cm(-2) light. Leishmania is highly sensitive to photoinactivation under conditions that have been previously demonstrated to maintain RBC properties during 42 days of storage.Keywords
This publication has 7 references indexed in Scilit:
- Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedsideTransfusion, 2006
- Pathogen inactivation ofLeishmania donovani infantumin plasma and platelet concentrates using riboflavin and ultraviolet lightVox Sanguinis, 2006
- Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage propertiesTransfusion, 2005
- LeishmaniasisAmerican Journal of Clinical Dermatology, 2002
- Clinical Spectrum of LeishmaniasisClinical Infectious Diseases, 1996
- Half-Strength Citrate CPD Combined with a New Additive Solution for Improved Storage of Red Blood Cells Suitable for Clinical UseVox Sanguinis, 1993
- New Perspectives on a Subclinical Form of Visceral LeishmaniasisThe Journal of Infectious Diseases, 1986